Corrigendum: Coexpression of HHLA2 and PD-L1 on tumor cells independently predicts the survival of spinal chordoma patients

[This corrects the article DOI: 10.3389/fimmu.2021.797407.].

Saved in:
Bibliographic Details
Published inFrontiers in immunology Vol. 14; p. 1194064
Main Authors Xia, Chao, Huang, Wei, Chen, Yun-Liang, Fu, Hai-Bin, Tang, Ming, Zhang, Tao-Lan, Li, Jing, Lv, Guo-Hua, Yan, Yi-Guo, Ouyang, Zhi-Hua, Yao, Nvzhao, Wang, Cheng, Zou, Ming-Xiang
Format Journal Article
LanguageEnglish
Published Switzerland Frontiers Media S.A 14.04.2023
Subjects
HHLA2
immune checkpoint molecules
Immunology
PD-L1
quantitative immunofluorescence
spinal chordoma
tumor infiltrating lymphocytes
PD-L1
spinal chordoma
immune checkpoint molecules
quantitative immunofluorescence
HHLA2
tumor infiltrating lymphocytes
Online AccessGet full text

Cover

More Information
Summary:[This corrects the article DOI: 10.3389/fimmu.2021.797407.].
Bibliography:corrigendum
SourceType-Other Sources-1
content type line 63
ObjectType-Correction/Retraction-1
These authors have contributed equally to this work
Approved by: Frontiers Editorial Office, Frontiers Media SA, Switzerland
This article was submitted to Cancer Immunity and Immunotherapy, a section of the journal Frontiers in Immunology
ISSN:1664-3224
1664-3224
DOI:10.3389/fimmu.2023.1194064